Thymulin vs Vilon
A side-by-side research comparison of Thymulin and Vilon across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Thymulin | Vilon |
|---|---|---|
| Full name | Thymulin (Facteur Thymique Serique) | Vilon (Lys-Glu Dipeptide Immune Bioregulator) |
| Category | Immune Support | Immune Support |
| Status | Research compound | Research compound (peptide bioregulator) |
| Mechanism | Binds to specific receptors on T-cell precursors promoting their differentiation into mature T-cells, modulates cytokine production, and requires zinc as cofactor. | As a very short signal peptide (Lys-Glu), it is proposed to bind DNA and modulate gene expression in immune and other tissues, influencing chromatin activity, cytokine balance, and cellular aging markers. |
| Molecular weight | 847.9 Da | ~275 Da |
| Half-life | ~2 hours | Short (peptide) |
| Bioavailability | ~80% subcutaneous | Oral (encapsulated) or subcutaneous |
| Typical dose | 1-5 mg | ~1-2 capsules/day or short injectable courses |
| Frequency | 2-3x per week | Once daily |
| Route | Subcutaneous injection | Oral capsule or subcutaneous |
Thymulin reported benefits
- T-cell maturation support
- Thymic function restoration
- Zinc-dependent immune activation
- Anti-inflammatory properties
Vilon reported benefits
- Immune regulation support
- Gene-expression modulation (proposed)
- Anti-aging tissue effects (proposed)
- Short course-based protocol
Related comparisons
Research and educational reference only. Not medical advice.